6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
US8912201B2 · kind B2 · utility
4Cited by
74References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 10, 2011 |
| Grant date | Dec 16, 2014 |
| Priority date | — |
| Expiry date | Aug 22, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to novel 6-cycloalkyl-pyrazolopyrimidinones according to formula (I)wherein R1, R2, D, m and n are as defined herein. The invention also relates to medicaments comprising these compounds and methods of using these compounds in the treatment of diseases and conditions, particularly diseases or conditions concerning deficits in perception, concentration, learning or memory.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.